Trump administration reveals Medicare drug price reductions for 15 medications
Medicare just got a hefty discount on 15 major drugs, courtesy of the Trump administration’s latest push to rein in skyrocketing healthcare costs.Late Tuesday, the administration unveiled negotiated price cuts for medications treating everything from cancer to diabetes, projecting a staggering $12 billion in savings compared to last year’s spending, with $685 million directly benefiting enrollees’ wallets by 2027, as The Hill reports.
This isn’t just a press release -- it’s a lifeline for millions of seniors struggling with prescription costs, especially for high-ticket items like Ozempic and Wegovy, used by nearly 2.3 million Medicare beneficiaries in 2024.
This negotiation program stems from the Inflation Reduction Act, a Biden administration hallmark now being wielded by Trump’s team to deliver results.
Health officials didn’t shy away from comparing their efforts to the prior administration’s initial round of talks, with CMS Administrator Mehmet Oz declaring, “Using the same process with a bolder direction, we have achieved substantially better outcomes for taxpayers and seniors in the Medicare Part D program.”
Meanwhile, advocacy groups like Patients For Affordable Drugs cheered the move as a win for taxpayers, though they rightly point out the fight against Big Pharma’s legal challenges isn’t over.
Read more...
3 comments:
I can’t afford a car so I had to walk to the store, and when I got there, there were no toys on the shelves. But at least no one said “Happy Holidays” to me.
Thou shalt not pretend that you're at war with drug traffickers while pardoning drug traffickers.
Although, as usual, your comment does not pertain to this blog, it is a highy controversial decision that Trump just made. Will see if his strategy works and he gets Honduras in our corner and not China's.
Post a Comment